PDCD1 and cancer: The importance of this axis is apparent in cancer and has led to the development of therapies blocking programmed cell death protein 1 (PD‐1) mediated T cell anergy to restore cytotoxic T cell anti‐cancer responses (Latchman et al., 2004; Liu et al., 2021).